Related Experiment Videos

Human defenses against Cryptococcus neoformans: an update

E Brummer1

  • 1Department of Medicine, California Institute for Medical Research, Santa Clara Valley Medical Center, San Jose, USA. E.Brummer@JUNO.com

Mycopathologia
|June 3, 1999
PubMed

Insights

Cryptococcus neoformans, a fungal pathogen, particularly affects AIDS patients. The body

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Cryptococcus neoformans var. neoformans is a global opportunistic fungal pathogen, notably affecting individuals with Acquired Immunodeficiency Syndrome (AIDS).
  • Cryptococcus neoformans var. gatti (CN-g) has a more restricted ecological niche, primarily associated with specific Eucalyptus tree species.
  • Alveolar macrophages (AM) represent the initial defense against Cryptococcus neoformans, providing a degree of resistance.

Purpose of the Study:

  • To define the inflammatory response and cytokine secretion by human alveolar macrophages (AM) during Cryptococcus neoformans infection.
  • To elucidate the roles of different immune cell populations and cytokines in host defense against Cryptococcus neoformans.

Main Methods:

  • The abstract does not specify the methods used in the study.

Main Results:

  • The inflammatory response, involving neutrophils and monocytes, constitutes a second line of defense, with inflammatory phagocytes demonstrating efficient killing of Cryptococcus neoformans.
  • T and B cell responses, including lymphokine (e.g., Interferon-gamma) and specific antibody production, form a third line of defense.
  • Interleukin-12 (IL-12) and Interleukin-18 (IL-18) enhance lymphocyte responses, appearing critical for controlling Cryptococcus neoformans infection.

Conclusions:

  • Alveolar macrophages and subsequent inflammatory cell influx are crucial for controlling Cryptococcus neoformans.
  • Adaptive immune responses, particularly T and B cell functions enhanced by IL-12 and IL-18, are vital for host defense.
  • AIDS patients' susceptibility is linked to low CD4+ T cell counts, compromising immune defenses against Cryptococcus neoformans.

Related Concept Videos